Search

SARS-CoV-2 pandemic is continuing to spread. There are growing concerns on the impact of COVID-19 in cancer patients. Several papers reporting recommendations and guidelines are published. But few data on cancer patients affected by COVID-19 are available. This is a retrospective study including all consecutive patients affected by gynecological cancer who developed COVID-19. All patients were treated in an academic setting (in Milan, Lombardy, Italy) between February and March 2020. Overall, 355 patients had active treatment during the study period due to newly diagnosed or recurrent gynecological disease. Among those, 19 (5.3%) patients affected developed COVID-19. All patients were asymptomatic at the time of COVID-19 detection. Six patients were diagnosed before starting planned treatments; while the remaining 13 were diagnosed for COVID-19 after their started their treatments. Considering the first group of six patients, one patient died due to COVID-19 3 days after the diagnosis; while the other patients recovered from COVID-19 after a median of three weeks. The latter group of 13 patients (treatments started) included five patients who underwent surgery and eight patients who underwent chemotherapy. Focusing on five patients who were diagnosed after surgery, we observed that two patients died during postoperative course, while in other two cases prolonged hospitalization was needed. One patient had no issues. Chemotherapy was delayed for the remaining patents without sequelae. Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance. • There are growing concerns on the impact of COVID-19 in cancer patients. • COVID-19 is impacting oncologic practice directly and indirectly. • Prioritizing patients journey during COVID-19 is of paramount importance. [ABSTRACT FROM AUTHOR]

We examine the relationship between incoming international passengers and COVID‐19 cases and deaths during the pandemic's initial wave in the United States. We find passengers from Milan, Italy, the location of an early outbreak, were an important source of exposure, increasing the early spread of COVID‐19 in the United States. Cities that received more passengers from Milan during the first quarter of 2020 experienced more COVID‐19 cases during March 2020 than cities receiving fewer passengers from Milan. Concurrently, cities that received more passengers from China or Rome (the latter not experiencing a major outbreak until later in 2020), did not experience increased cases. These results show passengers from at least one foreign epicenter were an important source of exposure that increased COVID‐19 spread in the United States. Given Milan was a secondary hotspot, our results also illustrate the importance of a holistic view of international pandemic hotspots when considering corresponding travel policy. [ABSTRACT FROM AUTHOR]